Percutaneous closure of the left atrial appendage for thromboembolic prevention in atrial fibrillation;Encerramento percutâneo do apêndice auricular esquerdo para profilaxia de tromboembolismo na fibrilhação auricular

Revista Portuguesa de Cardiologia

Volumn 32, Issue 4, 2013, Pages 311-323

  Faustino, Ana ^a   Paiva, Luís ^a   Providen̂cia, Rui ^a   Cacã̧o, Romeu ^a   Costa, Marco ^a   Leitão Marques, António ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Anticoagulation; Atrial fibrillation; Cardiac implant; Left atrial appendage; Stroke; Thromboembolism

Indexed keywords

HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; REVIEW; THROMBOEMBOLISM;

EID: 84879264799     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.06.017     Document Type: Short Survey

References (43)

1. Bonhorst D, Mendes M, Adragão P, et al. Prevalência de fibrilhação auricular na população portuguesa com 40 ou mais anos. Estudo FAMA. Rev Port Cardiol. 2010;29:331-50.
2. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429.
3. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: Executive summary. Eur Heart J. 2007;28:2803-17.
4. Contractor T, Khasnis A. Left atrial appendage closure in atrial fibrillation: A world without anticoagulation? Cardiol Res Pract. 2011;2011:1-7.
5. Sievert H, Bayard YL. Percutaneous closure of the left atrial appendage: A major step forward. JACC Cardiovasc Interv. 2009;2:601-2.
6. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31:967-75.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67. (Pubitemid 351650486)
8. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomized noninferiority trial. Lancet. 2009;374:534-42.
9. Fountain RB, Holmes DR, Chandrasekaran K, et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J. 2006;151:956-61.
10. Connolly SJ, Progue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066-78.
11. Connolly S, Progue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet. 2006;367:1903-12.
12. Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke. 2007;38:624-30. (Pubitemid 46184230)
13. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51.
14. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-91.
15. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-92.
16. Fuller CJ, Reisman M. Stroke prevention in atrial fibrillation: Atrial appendage closure. Curr Cardiol Rep. 2011;13:159-66.
17. Cairns JA, Connolly S, McMurtry S, et al., CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol. 2011;27:74-90.
18. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755-9. (Pubitemid 26060923)
19. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344:1411-20. (Pubitemid 32402097)
20. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49:1490-5. (Pubitemid 46505070)
21. Leithäuser B, Park JW. Cardioembolic stroke in aatrial fibrillation - Rationale for preventive closure of the left atrial appendage. Korean Circ J. 2009;39:443-58.
22. Kanderian AS, Gillinov AM, Petterson GB, et al. Success of surgical left atrial appendage closure - Assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52:924-9.
23. Healey JS, Crystal E, Lamy A, et al. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150:288-93. (Pubitemid 41116255)
24. Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation. NICE interventional procedures guidance 286. 2010. Disponível em: www.nice.org.uk /IPG286 [consultado 15 Jun 2011].
25. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: Executive summary. Circulation. 2006;114:449-528.
26. Bartus K, Bednarek J, Myc J, et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm. 2011;8:188-93.
27. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation. 2002;105:1887-9. (Pubitemid 34437613)
28. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46:9-14. (Pubitemid 40905122)
29. Park JW, Leithäuser B, Gerk U, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes. J Invasive Cardiol. 2009;21:446-50.
30. Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study. JACC Cardiovasc Interv. 2009;2:594-600.
31. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60:417-22. (Pubitemid 37356515)
32. Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: Initial European experience. Catheter Cardiovasc Interv. 2011;77:700-6.
33. Cruz-Gonzalez I, Martin Moreiras J, García E. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device. Catheter Cardiovasc Interv. 2011;78:970-3.
34. Cardona L, Ana G, Luísa B, et al. Thrombus formation on a left atrial appendage closure device. Circulation. 2011;124:1595-6.
35. Disponível em: www.mhra.gov.uk/home/groups/fsn/documents/ fieldsafetynotice/con108673.pdf [consultado 21 Fev 2012].
36. Plicht B, Kahlert P, Kälsch H, et al. Thrombus formation on the new amplatzer cardiac plug after LAA occlusion - a word of caution. Clin Res Cardiol. 2011;100. Abstract V905.
37. Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol. 2012;98:528-36.
38. Amplatzer Cardiac Plug Clinical Trial (ACP). Disponível em: www.clinicaltrials.gov/identificador: NCT01118299 [consultado 21 Fev 2012].
39. Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: Results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123:417-24.
40. ASA Plavix feasibility study with WATCHMAN left atrial appendage closure technology. Disponível em: www.clinicaltrials.gov/identificador: NCT00851578 [consultado 27 Fev 2012].
41. Reddy V, Neuzil P, Miller MA, et al. First formal analysis of the ASA Plavix Registry (ASAP): Watchman left atrial appendage closure in atrial fibrillation patients with contraindication to oral anticoagulation. In: Heart Rhythm Society 2012 Scientific Sessions. 2012. Abstract LB02-2.
42. Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: A PROTECT-AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol. 2012;59:923-9.
43. Evaluation of the WATCHMAN LAA closure device in patients with atrial fibrillation versus long term warfarin therapy (PREVAIL). Disponível em: www.clinicaltrials.gov/identificador: NCT011824 [consultado 27 Fev 2012].